Antoine Froissart

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center

Antoine Froissart, M. Buffet, Agnès Veyradier et al. · Critical Care Medicine · 2011 · 286 citations

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Aurélien Dinh, Jacques Ropers, Clara Duran et al. · The Lancet · 2021 · 153 citations

Community-acquired Pneumonia, Critical Care Medicine, Antibiotics +7

Infections Revealing Complement Deficiency in Adults

Alexandra Audemard‐Verger, Élodie Descloux, D. Ponard et al. · Medicine · 2016 · 33 citations · Full text

Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae

Jean‐Ralph Zahar, Philippe Lesprit, Stéphane Ruckly et al. · International Journal of Antimicrobial Agents · 2016 · 27 citations

Healthcare-associated Cases, Pathogenic Microbiology, Microbial Disease +11

Effect of a Red Blood Cell Transfusion on Biological Markers Used to Determine the Cause of Anemia: A Prospective Study

Antoine Froissart, Benjamín Rossi, Brigitte Ranque et al. · The American Journal of Medicine · 2017 · 13 citations

Anemia, Laboratory Hematology, Medicine +10